Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | SLC22A7 |
| Upstream (Parents) |
|---|
| (<<) APOM → SLC22A7 |
| Downstream (Children) |
|---|
| SLC22A7 → DGCR9 (>>) |
| SLC22A7 → GPD1 (>>) |
| SLC22A7 → SHC3 (>>) |
| SLC22A7 → PFKFB1 (>>) |
| SLC22A7 → GRIA4 (>>) |
| SLC22A7 → AR (>>) |
| SLC22A7 → DIO3 (>>) |
| SLC22A7 → GOLGA6L4///PML (>>) |
